We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. government and life sciences industry groups have asked Japan not to change the country’s drug pricing system to annual price reviews and cuts, instead of the current every-two-year review. Read More
The FDA issued Spanish API maker Interquim a warning letter for failing to establish adequate cleaning procedures and maintain quality records data in violation of GMP standards. Read More
Eli Lilly has filed its tenth lawsuit against a drugmaker in the U.S. District Court for the Eastern District of Virginia, alleging infringement of a patent that covers its erectile dysfunction drug Cialis. Read More